|Chemical name: Sitagliptin
Typical dosage: 100mg
Typical type: Tablet1
Januvia® is a medication used to treat type 2 diabetes. It is currently available as brand name only and comes in the form of an oral tablet.
Januvia is a prescription medication that contains the active ingredient Sitagliptin. Januvia is typically taken once daily and may be combined with insulin or other oral anti-diabetic medications.
Januvia is a DPP-4 inhibitor that stimulates the pancreas to secrete more insulin and stops the liver from producing sugars when blood sugar is high.
The major side effects of Januvia include headache, signs of a common cold, sore throat, stuffy nose and runny nose.
Yes! 95% of Medicare Advantage plans and Medicare Part D plans cover Januvia.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Januvia.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$42 – $519||$19 – $519|
Januvia should be used along with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. This medication may be given in combination with other drugs to adequately control your diabetes.
Patients who are 65 years of age and older may experience more side effects. Agents other than Januvia are considered safer in women who are pregnant and breastfeeding who require oral anti-diabetic therapy.
Patients taking Januvia sometimes experience joint pain that may occur within one day to years after starting treatment. This may be resolved by stopping Januvia therapy.
Other serious conditions such as blistered skin, heart failure and kidney problems have occurred in patients taking Januvia. Call your doctor immediately if you experience blisters or skin breakage, shortness of breath, noticeable weight gains or swelling in the arms and legs.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Join our Medicare Advantage email series.
By clicking "Join now" you are agreeing to receive emails from MedicareAdvantage.com
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Januvia. Retrieved May 2019, from www.goodrx.com/januvia.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.